open access

Vol 74, No 2 (2023)
Case report
Submitted: 2023-01-24
Accepted: 2023-05-02
Published online: 2023-06-30
Get Citation

Lambliasis-associated Schönlein-Henoch purpura in an Italian traveller: first case report in Italy

Antonio Mastroianni1, Sonia Greco1, Valeria Vangeli1, Maria Vittoria Mauro2, Francesca Greco2, Roberto Manfredi3
·
Pubmed: 37417841
·
IMH 2023;74(2):89-91.
Affiliations
  1. Infectious and Tropical Diseases Unit, “Annunziata” Hub Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy
  2. Microbiology and Virology Unit, “Annunziata” Hub Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy
  3. Infectious Diseases Institute, Alma Mater Studiorum University of Bologna, Bologna, Italy

open access

Vol 74, No 2 (2023)
TRAVEL/TROPICAL MEDICINE Case report
Submitted: 2023-01-24
Accepted: 2023-05-02
Published online: 2023-06-30

Abstract

A unique report of Schönlein-Henoch purpura (SHP) associated with a recent Giardia lamblia enteric infection
is described and discussed on the ground of the available literature. Tinidazole plus an appropriate
probiotic therapy, including Lactobacillus reuteri and vitamin D, proved to be effective in the condition.
SHP is an immunocomplex-mediated disorder characterised by a number of differently associated signs
and symptoms, leading to the possible involvement of the skin, joints, abdomen and kidneys. Recent
bacterial, viral, or protozoan infections may trigger the disease onset in patients of all ages. The paper describes
the first case of SHP triggered by a giardiasis. Tinidazole plus an appropriate probiotic therapy, i.e.
L. reuteri and vitamin D proved to be effective in this condition. To our knowledge, this is the first reported
case of lambliasis-associated SHP described in an international traveller.

Abstract

A unique report of Schönlein-Henoch purpura (SHP) associated with a recent Giardia lamblia enteric infection
is described and discussed on the ground of the available literature. Tinidazole plus an appropriate
probiotic therapy, including Lactobacillus reuteri and vitamin D, proved to be effective in the condition.
SHP is an immunocomplex-mediated disorder characterised by a number of differently associated signs
and symptoms, leading to the possible involvement of the skin, joints, abdomen and kidneys. Recent
bacterial, viral, or protozoan infections may trigger the disease onset in patients of all ages. The paper describes
the first case of SHP triggered by a giardiasis. Tinidazole plus an appropriate probiotic therapy, i.e.
L. reuteri and vitamin D proved to be effective in this condition. To our knowledge, this is the first reported
case of lambliasis-associated SHP described in an international traveller.

Get Citation

Keywords

Giardia lamblia, giardiasis, Schönlein-Henoch purpura, travel medicine

About this article
Title

Lambliasis-associated Schönlein-Henoch purpura in an Italian traveller: first case report in Italy

Journal

International Maritime Health

Issue

Vol 74, No 2 (2023)

Article type

Case report

Pages

89-91

Published online

2023-06-30

Page views

1338

Article views/downloads

434

DOI

10.5603/IMH.2023.0013

Pubmed

37417841

Bibliographic record

IMH 2023;74(2):89-91.

Keywords

Giardia lamblia
giardiasis
Schönlein-Henoch purpura
travel medicine

Authors

Antonio Mastroianni
Sonia Greco
Valeria Vangeli
Maria Vittoria Mauro
Francesca Greco
Roberto Manfredi

References (11)
  1. Tang C, Scaramangas-Plumley D, Nast CC, et al. A case of Henoch-Schonlein purpura associated with rotavirus infection in an elderly Asian male and review of the literature. Am J Case Rep. 2017; 18: 136–142.
  2. Pawłowska-Kamieniak A, Mroczkowska-Juchkiewicz A, Papierkowski A. [Henoch-Schoenlein purpura and toxocarosis]. Pol Merkur Lek. 1998; 4(22): 217–218.
  3. Janković S, Nikolić M, Simović A, et al. Henoch-Schönlein purpura associated with Strongyloides stercoralis infection. Vojnosanit Pregl. 2016; 73(5): 491–495.
  4. Tutanç M, Silfeler I, Ozgür T, et al. [The case of Henoch-Schönlein Purpura associated with Blastocystis hominis]. Turkiye Parazitol Derg. 2013; 37(2): 135–138.
  5. Thapa R, Mallick D, Biswas B, et al. Henoch-schonlein purpura triggered by falciparum cerebral malaria. Clin Pediatr (Phila). 2010; 49(7): 699–701.
  6. Hamidou MA, Gueglio B, Cassagneau E, et al. Henoch-Schönlein purpura associated with Toxocara canis infection. J Rheumatol. 1999; 26(2): 443–445.
  7. Bellanger AP, Bamoulid J, Millon L, et al. Rheumatoid purpura associated with toxocariasis. Can Fam Physician. 2011; 57(12): 1413–1414.
  8. Demircin G, Oner A, Erdoğan O, et al. Henoch Schönlein purpura and amebiasis. Acta Paediatr Jpn. 1998; 40(5): 489–491.
  9. Kim YOk, Choi YS, Won YHo, et al. Intestinal amebiasis with Henoch-Schönlein purpura. Pediatr Int. 2010; 52(4): 667–669.
  10. Ergür AT, Cetinkaya O, Onarlioğlu B. Paediatric patients with Henoch-Schönlein purpura followed up at Cumhuriyet University, Sivas, Turkey during 1993-1996: role of parasitosis in the aetiology of Henoch-Schönlein purpura. J Trop Pediatr. 1999; 45(3): 177–178.
  11. Reitano U, Fondacaro A. [Schönlein-Henoch syndrome from ascarids]. Acta Med Ital Mal Infett Parassit. 1950; 5(11): 388–392.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl